UniProt ID | PNCB_HUMAN | |
---|---|---|
UniProt AC | Q6XQN6 | |
Protein Name | Nicotinate phosphoribosyltransferase | |
Gene Name | NAPRT | |
Organism | Homo sapiens (Human). | |
Sequence Length | 538 | |
Subcellular Localization | Cytoplasm, cytosol . | |
Protein Description | Catalyzes the conversion of nicotinic acid (NA) to NA mononucleotide (NaMN). Essential for NA to increase cellular NAD levels and prevent oxidative stress of the cells.; Catalyzes the synthesis of beta-nicotinate D-ribonucleotide from nicotinate and 5-phospho-D-ribose 1-phosphate at the expense of ATP.. | |
Protein Sequence | MAAEQDPEARAAARPLLTDLYQATMALGYWRAGRARDAAEFELFFRRCPFGGAFALAAGLRDCVRFLRAFRLRDADVQFLASVLPPDTDPAFFEHLRALDCSEVTVRALPEGSLAFPGVPLLQVSGPLLVVQLLETPLLCLVSYASLVATNAARLRLIAGPEKRLLEMGLRRAQGPDGGLTASTYSYLGGFDSSSNVLAGQLRGVPVAGTLAHSFVTSFSGSEVPPDPMLAPAAGEGPGVDLAAKAQVWLEQVCAHLGLGVQEPHPGERAAFVAYALAFPRAFQGLLDTYSVWRSGLPNFLAVALALGELGYRAVGVRLDSGDLLQQAQEIRKVFRAAAAQFQVPWLESVLIVVSNNIDEEALARLAQEGSEVNVIGIGTSVVTCPQQPSLGGVYKLVAVGGQPRMKLTEDPEKQTLPGSKAAFRLLGSDGSPLMDMLQLAEEPVPQAGQELRVWPPGAQEPCTVRPAQVEPLLRLCLQQGQLCEPLPSLAESRALAQLSLSRLSPEHRRLRSPAQYQVVLSERLQALVNSLCAGQSP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Phosphorylation | AAARPLLTDLYQATM HHHHHHHHHHHHHHH | 31.47 | 22673903 | |
21 | Phosphorylation | RPLLTDLYQATMALG HHHHHHHHHHHHHHC | 10.02 | 27259358 | |
24 | Phosphorylation | LTDLYQATMALGYWR HHHHHHHHHHHCCHH | 6.35 | 22673903 | |
163 | Ubiquitination | RLIAGPEKRLLEMGL HHHHCHHHHHHHHHH | 52.02 | 21906983 | |
163 (in isoform 3) | Ubiquitination | - | 52.02 | 21906983 | |
163 (in isoform 2) | Ubiquitination | - | 52.02 | 21906983 | |
163 (in isoform 1) | Ubiquitination | - | 52.02 | 21906983 | |
163 | 2-Hydroxyisobutyrylation | RLIAGPEKRLLEMGL HHHHCHHHHHHHHHH | 52.02 | - | |
179 | Ubiquitination | RAQGPDGGLTASTYS HHCCCCCCCCHHCEE | 27.51 | 27667366 | |
186 | Ubiquitination | GLTASTYSYLGGFDS CCCHHCEEECCCCCC | 17.61 | 24816145 | |
193 | Ubiquitination | SYLGGFDSSSNVLAG EECCCCCCCCCCCCH | 33.14 | 21963094 | |
213 | Phosphorylation | PVAGTLAHSFVTSFS CCCHHHCCCHHHCCC | 25.53 | - | |
380 | Ubiquitination | VNVIGIGTSVVTCPQ EEEEEECCCEEECCC | 19.21 | 27667366 | |
387 | Ubiquitination | TSVVTCPQQPSLGGV CCEEECCCCCCCCCE | 70.71 | 24816145 | |
394 | Ubiquitination | QQPSLGGVYKLVAVG CCCCCCCEEEEEEEC | 3.46 | 21963094 | |
396 | Ubiquitination | PSLGGVYKLVAVGGQ CCCCCEEEEEEECCC | 33.79 | - | |
405 | Methylation | VAVGGQPRMKLTEDP EEECCCCCCCCCCCC | 27.29 | 115484459 | |
407 (in isoform 1) | Ubiquitination | - | 54.24 | 21906983 | |
407 | Ubiquitination | VGGQPRMKLTEDPEK ECCCCCCCCCCCCCC | 54.24 | 21906983 | |
407 (in isoform 3) | Ubiquitination | - | 54.24 | 21906983 | |
407 (in isoform 2) | Ubiquitination | - | 54.24 | 21906983 | |
414 | Ubiquitination | KLTEDPEKQTLPGSK CCCCCCCCCCCCCCH | 54.71 | 21906983 | |
414 (in isoform 1) | Ubiquitination | - | 54.71 | 21906983 | |
414 (in isoform 2) | Ubiquitination | - | 54.71 | 21906983 | |
414 (in isoform 3) | Ubiquitination | - | 54.71 | 21906983 | |
416 | Phosphorylation | TEDPEKQTLPGSKAA CCCCCCCCCCCCHHH | 46.09 | - | |
420 | Phosphorylation | EKQTLPGSKAAFRLL CCCCCCCCHHHHHHH | 19.72 | 20068231 | |
421 (in isoform 2) | Ubiquitination | - | 50.04 | 21906983 | |
421 (in isoform 1) | Ubiquitination | - | 50.04 | 21906983 | |
421 (in isoform 3) | Ubiquitination | - | 50.04 | 21906983 | |
421 | Ubiquitination | KQTLPGSKAAFRLLG CCCCCCCHHHHHHHC | 50.04 | 27667366 | |
429 | Phosphorylation | AAFRLLGSDGSPLMD HHHHHHCCCCCCHHH | 38.47 | 24719451 | |
432 | Phosphorylation | RLLGSDGSPLMDMLQ HHHCCCCCCHHHHHH | 21.61 | 28348404 | |
480 | Ubiquitination | LLRLCLQQGQLCEPL HHHHHHHCCCCCCCC | 28.75 | 27667366 | |
487 | Ubiquitination | QGQLCEPLPSLAESR CCCCCCCCCCHHHHH | 1.78 | 24816145 | |
494 | Ubiquitination | LPSLAESRALAQLSL CCCHHHHHHHHHHHH | 25.73 | 21963094 | |
500 | Phosphorylation | SRALAQLSLSRLSPE HHHHHHHHHHHCCHH | 16.54 | 20068231 | |
502 | Phosphorylation | ALAQLSLSRLSPEHR HHHHHHHHHCCHHHH | 28.00 | 20068231 | |
505 | Phosphorylation | QLSLSRLSPEHRRLR HHHHHHCCHHHHHCC | 27.42 | 23186163 | |
513 | Phosphorylation | PEHRRLRSPAQYQVV HHHHHCCCHHHHHHH | 29.22 | 28450419 | |
517 | Phosphorylation | RLRSPAQYQVVLSER HCCCHHHHHHHHHHH | 12.84 | 28857561 | |
522 | Phosphorylation | AQYQVVLSERLQALV HHHHHHHHHHHHHHH | 14.73 | 24719451 | |
531 | Phosphorylation | RLQALVNSLCAGQSP HHHHHHHHHHCCCCC | 19.83 | 23403867 | |
537 | Phosphorylation | NSLCAGQSP------ HHHHCCCCC------ | 31.49 | 23927012 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PNCB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PNCB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PNCB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HSP7C_HUMAN | HSPA8 | physical | 22863883 | |
NOL3_HUMAN | NOL3 | physical | 22863883 | |
PA1B2_HUMAN | PAFAH1B2 | physical | 22863883 | |
RASL1_HUMAN | RASAL1 | physical | 22863883 | |
K1C40_HUMAN | KRT40 | physical | 25416956 | |
CCD57_HUMAN | CCDC57 | physical | 25416956 | |
ARMT1_HUMAN | C6orf211 | physical | 26344197 | |
EF1A1_HUMAN | EEF1A1 | physical | 26344197 | |
NIF3L_HUMAN | NIF3L1 | physical | 26344197 | |
SEC13_HUMAN | SEC13 | physical | 26344197 | |
SC31A_HUMAN | SEC31A | physical | 26344197 | |
TCEA1_HUMAN | TCEA1 | physical | 26344197 | |
TNR6C_HUMAN | TNRC6C | physical | 26344197 | |
TR112_HUMAN | TRMT112 | physical | 26344197 | |
EKI1_HUMAN | ETNK1 | physical | 28514442 | |
LCAP_HUMAN | LNPEP | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-537, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-537, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-537, AND MASSSPECTROMETRY. |